Table 3 Epidemiological and clinicopathological characteristics of patients by age
Characteristic | Age (n/%) | Total | |||
|---|---|---|---|---|---|
≤ 29 | 30–39 | 40–49 | 50–54 | ||
Count | 6 (1.7%) | 34 (9.9%) | 132 (38.2%) | 173 (50.1%) | 345 (100%) |
Sex | |||||
Male | 3 (0.9%) | 19 (5.5%) | 69 (20.0%) | 91 (26.0%) | 182 (52.8%) |
Female | 3 (0.9%) | 15 (4.3%) | 63 (18.0%) | 82 (23.8%) | 163 (47.2%) |
Presentation | |||||
Elective | 2 (0.6%) | 21 (6.1%) | 95 (27.5%) | 89 (25.8%) | 207 (60.0%) |
Emergency | 3 (0.9%) | 12 (3.5%) | 33 (9.6%) | 28 (8.1%) | 76 (22.0%) |
Screening | 0 | 0 | 1 (0.3%) | 52 (15.1%) | 53 (15.4%) |
Incidental | 0 | 0 | 1 (0.3%) | 1 (0.3%) | 2 (0.6%) |
Unknown | 1 (0.3%) | 1 (0.3%) | 2 (0.6%) | 3 (0.9%) | 7 (2.0%) |
Past Medical History | |||||
IBD | 0 | 4 (1.2%) | 3 (0.9%) | 7 (2.0%) | 14 (4.1%) |
Previous cancer | 0 | 1 (0.3%) | 4 (1.2%) | 9 (2.6%) | 14 (4.1%) |
Alcoholism | 0 | 2 (0.6%) | 12 (3.5%) | 14 (4.1%) | 28 (8.1%) |
Numerical Stage | |||||
I | 0 | 2 (0.6%) | 12 (3.5%) | 27 (7.8%) | 41 (11.9%) |
II | 2 (0.6%) | 5 (14.5%) | 37 (10.7%) | 46 (13.3%) | 90 (26.1%) |
III | 3 (0.9%) | 16 (4.6%) | 59 (17.1%) | 68 (19.7%) | 146 (42.3%) |
IV | 1 (0.3%) | 10 (2.9%) | 23 (6.7%) | 31 (9.0%) | 65 (18.8%) |
Tumour Location | |||||
Right | 1 (0.3%) | 6 (1.7%) | 18 (5.2%) | 35 (10.1%) | 60 (17.4%) |
Left | 3 (0.9%) | 12 (3.5%) | 53 (15.4%) | 61 (17.7%) | 129 (37.4%) |
Rectal | 2 (0.6%) | 16 (4.6%) | 55 (15.9%) | 74 (21.4%) | 147 (42.6%) |
Transverse | 0 | 0 | 3 (0.9%) | 2 (0.6%) | 5 (1.4%) |
Tumour Differentiation | |||||
Well | 0 | 0 | 2 (0.6%) | 3 (0.9%) | 4 (1.2%) |
Medium | 5 (1.4%) | 23 (6.7%) | 106 (30.7%) | 137 (39.7%) | 271 (78.6%) |
Poor | 1 (0.3%) | 8 (2.3%) | 17 (4.9%) | 16 (4.6%) | 42 (12.2%) |
Undocumented | 0 | 3 (0.9%) | 8 (2.3%) | 17 (4.9%) | 28 (8.1%) |
Management | |||||
Surgical | 5 (1.4%) | 27 (7.8%) | 117 (33.9%) | 155 (44.9%) | 304 (88.1%) |
Palliative | 1 (0.3%) | 6 (1.7%) | 14 (4.1%) | 16 (4.6%) | 37 (10.7%) |
Chemotherapy Received | 5 (1.4%) | 31 (9.0%) | 110 (31.9%) | 133 (38.6%) | 279 (80.9%) |
Radiotherapy Received | 0 | 14 (4.1%) | 42 (12.2%) | 61 (17.7%) | 117 (33.9%) |
Tumour Recurrence | 0 | 5 (1.4%) | 40 (11.6%) | 33 (9.6%) | 78 (22.6%) |
Patient Deceased | 3 (0.9%) | 14 (4.1%) | 42 (12.2%) | 55 (15.9%) | 114 (33.0%) |